company background image
506128 logo

Parnax Lab BSE:506128 Stock Report

Last Price

₹119.10

Market Cap

₹1.4b

7D

-1.2%

1Y

25.8%

Updated

07 Oct, 2024

Data

Company Financials

506128 Stock Overview

Manufactures and sells pharmaceutical formulations in India and internationally.

506128 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health2/6
Dividends0/6

Parnax Lab Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Parnax Lab
Historical stock prices
Current Share Price₹119.10
52 Week High₹167.90
52 Week Low₹75.60
Beta0.79
11 Month Change-6.59%
3 Month Change20.06%
1 Year Change25.78%
33 Year Change350.28%
5 Year Change430.51%
Change since IPO1,317.86%

Recent News & Updates

Recent updates

Shareholder Returns

506128IN PharmaceuticalsIN Market
7D-1.2%-1.3%-3.6%
1Y25.8%59.4%40.0%

Return vs Industry: 506128 underperformed the Indian Pharmaceuticals industry which returned 59.4% over the past year.

Return vs Market: 506128 underperformed the Indian Market which returned 40% over the past year.

Price Volatility

Is 506128's price volatile compared to industry and market?
506128 volatility
506128 Average Weekly Movement4.8%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.1%
10% most volatile stocks in IN Market9.3%
10% least volatile stocks in IN Market3.9%

Stable Share Price: 506128 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 506128's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
198212Mihir Shahwww.naxparlab.com

Parnax Lab Limited manufactures and sells pharmaceutical formulations in India and internationally. The company offers pharmaceutical products in the form of liquids, ointments, gels, creams, tablets, and capsules; and medicinal products. It provides cosmetic products; herbal; and nutraceutical products.

Parnax Lab Limited Fundamentals Summary

How do Parnax Lab's earnings and revenue compare to its market cap?
506128 fundamental statistics
Market cap₹1.37b
Earnings (TTM)₹102.68m
Revenue (TTM)₹1.90b

13.3x

P/E Ratio

0.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
506128 income statement (TTM)
Revenue₹1.90b
Cost of Revenue₹987.80m
Gross Profit₹913.10m
Other Expenses₹810.42m
Earnings₹102.68m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)8.94
Gross Margin48.04%
Net Profit Margin5.40%
Debt/Equity Ratio112.5%

How did 506128 perform over the long term?

See historical performance and comparison